2025³â 08¿ù 05ÀÏ È­¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92443°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

¡®¹®ÇÐÀ¸·Î ¸¸µå´Â ¸¶À½ÀÇ Æò¾È, ±Ý°­À§Å©¡¯ °³ÃÖ

»ó¼³ üÇèºÎÅÍ »ê»ç Äܼ­Æ®, ¸í»çÃÊû¹ýȸ±îÁö¡¦ ½ÅÁß³âÃþ ¸ÂÃã ÇÁ·Î±×·¥
º¸ÇöÇà¿øÀ» ½ÇõÇÏ´Â Àü¹ýµµ·® ´ëÇѺұ³Á¶°èÁ¾ ±Ý°­Á¤»ç(ÁÖÁö °¡¼·½º´Ô)°¡ 8¿ù 1ÀϺÎÅÍ 10¿ù 31ÀϱîÁö 3°³¿ù°£ ¹®ÇÐÀ» ÅëÇÑ ¸¶À½ Ä¡À¯ ÇÁ·Î±×·¥ ‘Á¦3ȸ ¹®ÇÐÀ¸·Î ¸¸µå´Â ¸¶À½ÀÇ Æò¾È, ±Ý°­À§Å©(ÁÖÃÖ ¹× ÁÖ°ü: ´ëÇѺұ³Á¶°èÁ¾ ±Ý°­Á¤»ç, ÈÄ¿ø: °æ±âµµ)’¸¦ ÁøÇàÇÑ´Ù°í 30ÀÏ ¹àÇû´Ù. °æ±âµµ ±¤¸í½Ã¿¡ À§Ä¡ÇÑ ±Ý°­Á¤»ç´Â ȸÁÖ½º´ÔÀ̽Šº®¾Ï(ÁöÈ«)½º´Ô°ú Àç°¡ºÒÀÚµéÀÇ ¿ø·ÂÀ¸·Î ºÒ±â 2535³â(1991³â) 1¿ù °³¿øÇÑ ½ÅÇà °øµ¿Ã¼´Ù. È£¹ý¹ýȸ ¹× ÀÏ¿ä¹ýȸ µî ´Ù¾çÇÑ Á¤±â¹ýȸ¸¦ ºñ·ÔÇØ ‘³» ¸¶À½ÀÇ Çູ¿©Çà(1¹Ú2ÀÏ Ã¼ÇèÇü)&rs ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
¡®»ç¶ûÀº¡¯ À±¹Ú, ¹Ú·Â°í¹é... ¸Å·Â ´ëÆø¹ß (2019-12-08)
¾Æ¿ôµµ¾î ·¹µåÆäÀ̽º, ¡®»Ç±ÛÀÌ¡¯ Çø®½º ÀçŶ (2020-10-21)
°æºÏ µþ±â ¡®½ÑŸ¡¯ Áß±¹¿¡¼­ »óÇ¥±Ç µî·Ï (2013-02-16)
SKÅÚ·¹ÄÞ, ¡®´©±¸ ÄÜÆÛ·±½º 2021¡¯ °³ÃÖ (2021-10-04)
º£½ºÆ®¾ÆÀ̵¹, °­´Ù´Ï¿¤, ¹æÅº¼Ò³â´Ü, ¹Ì¾ß¿ÍŰ »çÄí¶ó 1À§ (2018-11-05)
Çö´ëÀÚµ¿Â÷, 2¿ù 32¸¸7718´ë ÆÇ¸Å (2023-03-05)
Belkin International Awarded for Global Sustainability in th... (2022-09-07)
Andersen Global Establishes Presence in Bangladesh with Coll... (2022-03-02)
û³ââ¾÷¡¤º¥Ã³±â¾÷ Áö¿ø À°¼º ¸ðÅÂÆÝµå µµÀÔ (2019-09-09)
ÀÏÀÚ¸® ÀÚµ¿»ó´ã ¼­ºñ½º 꺿 ¡®°í¿ëÀÌ¡¯ ½Ã¹ü ¼­ºñ½º (2019-03-04)
ÇÑÀü¡¤°æºÏµµ, °¡Ãà ºÐ´¢ Ȱ¿ë ¹ßÀü±â¼ú °³¹ß (2020-08-22)
¾ÆÀ̵éÀÌ ÇູÇÑ ½Ç³»½£ ¸¸µé¾î¿ä (2022-02-10)
9±Þ °ø¹«¿ø ¸éÁ¢µµ ÀÌÁ¦´Â Àü·« (2014-08-06)
º¸Çè »ç±â ÀÎÁö ½Ã½ºÅÛ °íµµÈ­·Î º¸Çè »ç±â °ü¸® (2018-01-30)
»çȸÀû°æÁ¦Á¶Á÷ ÇØ¿ÜÁøÃâ Áö¿ø»ç¾÷ (2022-01-31)
·ÎÁöÀÇ ÁøÈ­, À¯Æ©ºê¿¡ MC·Î µîÀå (2022-01-31)
°øÀÎÀÎÁõ¼­, ¿Ü±¹¿¡¼­µµ ¹ß±Þ °¡´É (2013-01-16)
ÀϺ» ¼öÃâ±ÔÁ¦ ´ëÀÀ °ü°èÀå°üȸÀÇ (2019-07-21)
±¹³» ÃÖÃÊ µ¿³²¾Æ½Ã¾Æ¹®ÇÐ ÀüÁý (2022-01-21)
KB±¹¹ÎÀºÇà, ¡®KBµÎ±ÙµÎ±Ù¿©ÇàÀû±Ý¡¯ Ãâ½Ã (2021-07-16)
Åë½Å3»ç, °øÀξ˸²¹®ÀÚ ¼­ºñ½º °øµ¿ °³½Ã (2022-01-11)
±Ý¼Ò¿¬, ¿ÃÇØ ±ÝÀ¶¼ÒºñÀÚ 10´ë ´º½º ¼±Á¤ (2019-12-27)
»ï¼ºÀüÀÚ, ¡®ºñ½ºÆ÷Å© ¾Æ¶ã¸®¿¡¡¯ °ø°³ (2021-07-06)
Æòâ¼Û¾îÃàÁ¦, ÀÌ»ó°í¿Â Çö»ó¿¡ °³¸· ¿¬±â (2019-12-17)
½À°üÀ» Á¶±Ý ¹Ù²åÀ» »ÓÀε¥ Àß Ç®¸®±â ½ÃÀÛÇß´Ù (2020-12-19)
       [ÀÌÀü][1]....[3070][3071][3072][3073][3074][3075][3076][3077][3078]...[3698][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..